In this regard, corroborating an early investigation in Drosophila [15], recent studies on SMA mouse models demonstrated that restoring SMN expression pan-neuronally has minimal beneficial effects [16] whereas an increase in SMN levels in all tissues minus the central nervous system was sufficient for phenotypic rescue [17]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.